Skip to main content
logo
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada · Delayed Price · Currency is CAD
2.590
+0.020 (0.78%)
May 8, 2026, 9:30 AM EST

COSCIENS Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.59.597.1414.575.26
Revenue Growth (YoY)
-21.79%34.22%-50.98%177.03%44.03%
Cost of Revenue
4.934.864.216.020.09
Gross Profit
2.574.732.948.565.17
Selling, General & Admin
10.066.375.532.877.27
Research & Development
2.958.32.041.376.57
Operating Expenses
13.0114.677.574.2413.84
Operating Income
-10.44-9.94-4.634.32-8.67
Interest Expense
-0.17-0.13-0.14-0.14-0.01
Interest & Investment Income
0.280.440.060.15-
Currency Exchange Gain (Loss)
-0.20.05-0.020.210.22
Other Non Operating Income (Expenses)
0.412.70.36-0.01-0.01
EBT Excluding Unusual Items
-10.11-6.89-4.374.53-8.48
Merger & Restructuring Charges
--4.08---
Asset Writedown
-0.24-4.26---
Pretax Income
-10.35-15.23-4.374.53-8.48
Income Tax Expense
0.010.08-0.891.08-0.11
Earnings From Continuing Operations
-10.36-15.31-3.493.45-8.37
Net Income
-10.36-15.31-3.493.45-8.37
Net Income to Common
-10.36-15.31-3.493.45-8.37
Shares Outstanding (Basic)
33221
Shares Outstanding (Diluted)
33221
Shares Change (YoY)
22.62%39.74%-0.39%61.37%179.74%
EPS (Basic)
-3.27-5.93-1.891.87-7.28
EPS (Diluted)
-3.27-5.93-1.891.86-7.28
Free Cash Flow
-9.18-15.73-3.34.93-8.61
Free Cash Flow Per Share
-2.90-6.09-1.792.66-7.49
Gross Margin
34.29%49.33%41.13%58.71%98.29%
Operating Margin
-139.25%-103.70%-64.81%29.65%-164.85%
Profit Margin
-138.14%-159.69%-48.79%23.66%-159.09%
Free Cash Flow Margin
-122.42%-164.07%-46.26%33.80%-163.71%
EBITDA
-9.52-8.68-3.195.79-8.53
EBITDA Margin
-126.90%-90.52%-44.60%39.72%-162.09%
D&A For EBITDA
0.931.261.441.470.15
EBIT
-10.44-9.94-4.634.32-8.67
EBIT Margin
-139.25%-103.70%-64.81%29.65%-164.85%
Effective Tax Rate
---23.85%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.